PURPOSE: To estimate cancer screening coverage among a large sample of Greek individuals. METHODS: 7012 adults from 30 Hellenic areas were surveyed. Tests included: faecal occult blood test, sigmoidoscopy,chest X-ray, urine test, testicular examination,trans-rectal ultrasound, full blood count, skin examination,digital rectal examination, PSA, Pap test, mammography,clinical breast examination (CBE), self breast examination and breast ultrasound. RESULTS: Eighty-eight percent of males and 93% of females declared being interested in cancer screening; 37.8% of men and 37.9% of women had had a medical consultation for screening purpose in the previous 2 years. Less than 2%reported having received screening for colorectal cancer or skin malignancies. Screening for cervical cancer, mammography and CBE was reported by 39.6%, 22.8% and 27.9% of females respectively. Twenty percent of males reported screening for prostate cancer. CONCLUSION: The actual opportunistic screening approach presents important deficiencies with displaced priorities in test performance and a low proportion of individuals undergoing recommended tests.
PURPOSE: To estimate cancer screening coverage among a large sample of Greek individuals. METHODS: 7012 adults from 30 Hellenic areas were surveyed. Tests included: faecal occult blood test, sigmoidoscopy,chest X-ray, urine test, testicular examination,trans-rectal ultrasound, full blood count, skin examination,digital rectal examination, PSA, Pap test, mammography,clinical breast examination (CBE), self breast examination and breast ultrasound. RESULTS: Eighty-eight percent of males and 93% of females declared being interested in cancer screening; 37.8% of men and 37.9% of women had had a medical consultation for screening purpose in the previous 2 years. Less than 2%reported having received screening for colorectal cancer or skin malignancies. Screening for cervical cancer, mammography and CBE was reported by 39.6%, 22.8% and 27.9% of females respectively. Twenty percent of males reported screening for prostate cancer. CONCLUSION: The actual opportunistic screening approach presents important deficiencies with displaced priorities in test performance and a low proportion of individuals undergoing recommended tests.
Authors: J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman Journal: N Engl J Med Date: 2000-11-30 Impact factor: 91.245
Authors: D Mauri; K Kamposioras; N P Polyzos; F J Rivas Flores; H Altinoz; M Chojnacka; I Karentzou; M Dambrosio; C Colichi; T Oxiuzova; E Kanavoura; B A M da Silva Alves de Sousa; D Ivanova; J Mauri; V Karampoiki; A Maragkaki; A Xilomenos Journal: Exp Oncol Date: 2006-09
Authors: G Gatta; R Capocaccia; M P Coleman; L A Gloeckler Ries; T Hakulinen; A Micheli; M Sant; A Verdecchia; F Berrino Journal: Cancer Date: 2000-08-15 Impact factor: 6.860
Authors: Milena Sant; Claudia Allemani; Franco Berrino; Michel P Coleman; Tiiu Aareleid; Gilles Chaplain; Jan Willem Coebergh; Marc Colonna; Paolo Crosignani; Arlette Danzon; Massimo Federico; Lorenzo Gafà; Pascale Grosclaude; Guy Hédelin; Josette Macè-Lesech; Carmen Martinez Garcia; Henrik Møller; Eugenio Paci; Nicole Raverdy; Brigitte Tretarre; Evelyn M I Williams Journal: Cancer Date: 2004-02-15 Impact factor: 6.860
Authors: L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund Journal: Lancet Date: 1985-04-13 Impact factor: 79.321